Related Experiment Video
Updated: Mar 13, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Plumbagin Disrupts Biofilm Integrity and Resistance Gene Expression in Carbapenem-Resistant Acinetobacter baumannii
Min-Ji Youn1, Yong-Bin Eom1,2
1Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, Asan, Chungnam 31538, Republic of Korea.
Abstract:
Carbapenem-resistant Acinetobacter baumannii (CRAB) has appeared as a leading cause of hospital-acquired infections, resulting in high mortality rates and limited treatment options. The development of novel antibacterial agents has lagged behind the rapid spread of antibiotic-resistant bacteria; thus, alternative therapeutic strategies are urgently needed. In this study, we investigated plumbagin, a natural compound derived from Plumbago zeylanica L., for its potential antibacterial and antibiofilm activities against CRAB. MIC and MBC determinations showed that plumbagin significantly inhibited growth and exerted bactericidal activity at low concentrations. Biofilm inhibition concentration and biofilm eradication concentration assays revealed that plumbagin both prevented biofilm formation and eradicated mature biofilms. Consistent with these findings, XTT reduction assays showed a marked decrease in metabolic activity after plumbagin treatment, and confocal laser scanning microscopy with COMSTAT analysis confirmed reduced biofilm biomass and decreased viability of biofilm-embedded cells. Further, quantitative polymerase chain reaction confirmed the downregulation of the carbapenem-resistance gene blaOXA-23 and biofilm-related genes, including bfmR, csuA/B, ompA, and bap. Collectively, these results reveal plumbagin as a therapeutic candidate against CRAB.
Insights
Plumbagin, a natural compound, shows significant antibacterial and antibiofilm activity against carbapenem-resistant Acinetobacter baumannii (CRAB). This compound effectively inhibits CRAB growth, eradicates biofilms, and downregulates key resistance genes, offering a promising therapeutic candidate.
Area of Science:
- Microbiology
- Pharmacology
- Natural Products Chemistry
Background:
- Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant threat as a cause of hospital-acquired infections.
- High mortality rates and limited treatment options underscore the urgent need for novel therapeutic strategies against CRAB.
- The rapid spread of antibiotic resistance necessitates exploring alternative antibacterial agents.
Purpose of the Study:
- To investigate the antibacterial and antibiofilm potential of plumbagin, a natural compound from *Plumbago zeylanica* L., against CRAB.
- To evaluate plumbagin's efficacy in inhibiting CRAB growth and preventing/eradicating biofilms.
- To elucidate the molecular mechanisms underlying plumbagin's activity, including its effect on resistance and biofilm-related genes.
Main Methods:
- Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays to determine plumbagin's growth inhibition and bactericidal activity.
- Biofilm inhibition and eradication assays, coupled with XTT reduction assays and confocal laser scanning microscopy (CLSM) with COMSTAT analysis, to assess antibiofilm effects.
- Quantitative polymerase chain reaction (qPCR) to analyze the expression of the carbapenem-resistance gene *bla*OXA-23 and key biofilm-related genes (*bfmR*, *csuA/B*, *ompA*, *bap*).
Main Results:
- Plumbagin demonstrated significant inhibition of CRAB growth and bactericidal activity at low concentrations.
- Plumbagin effectively prevented biofilm formation and eradicated established biofilms, evidenced by reduced metabolic activity and biofilm biomass.
- qPCR analysis revealed that plumbagin downregulated the expression of *bla*OXA-23, *bfmR*, *csuA/B*, *ompA*, and *bap* genes.
Conclusions:
- Plumbagin exhibits potent antibacterial and antibiofilm activities against carbapenem-resistant *Acinetobacter baumannii*.
- Plumbagin's ability to inhibit growth, disrupt biofilms, and downregulate resistance/biofilm genes positions it as a promising therapeutic candidate.
- Further research into plumbagin could lead to novel treatments for CRAB infections, addressing a critical unmet medical need.
More Related Videos
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Development of Antibiotic Resistance